BCRB 2018

19/09/2018

Acneiform rash

• Prominent cetuximab-induced rash ~ better survival

Bonner JA, Lancet Oncol 2010

Predictive biomarkers for cetuximab in HNSCC?

Bonner J Oncologist 2017;22:811

Patients with p16+ tumors had superior OS than those with p16- tumors in both the cetuximab + RT arm and RT alone treatment arm. Although the treatment effects were stronger in the p16+ subgroup, interaction tests revealed no significant interaction between p16 status and treatment

9